Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Endocrinology].

P Meyer1, C A Meier

  • 1Unite d'endocrinologie HUG, 121 I Genève 14. patrick.meyer@hcuge.ch

Revue Medicale Suisse
|February 10, 2006
PubMed
Summary
This summary is machine-generated.

Risks of hormone replacement therapy and low-dose oral contraceptives outweigh benefits. For hypothyroidism, T3 addition to T4 is not beneficial, and Chinese herbal products may contain harmful hormones.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The metabolic syndrome: benefits (or not) in practice].

Revue medicale suisse·2011
Same author

Thoughts about medical and non-medical psychotherapy.

Schweizerische Zeitschrift fur Psychologie und ihre Andwendungen. Revue suisse de psychologie, pure et appliquee·2010
Same author

[10 years of lipodystrophy--and so many uncertainties].

Revue medicale suisse·2009
Same author

Gender-based dimorphic pattern for interleukin-1 receptor antagonist in type 2 diabetes mellitus.

Diabetes & metabolism·2008
Same author

[Secretion o cytokines by adipose tissue: metabolic and vascular effects].

Journees annuelles de diabetologie de l'Hotel-Dieu·2006
Same author

Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection.

Alimentary pharmacology & therapeutics·2006
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

[Erythema multiforme : target deciphering].

Revue medicale suisse·2026
See all related articles

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Pharmacology

Context:

  • Evidence suggests hormone replacement therapy (HRT) risks exceed benefits in post-menopausal women.
  • Current low-dose oral contraceptives (OCs) are linked to increased thrombotic event risk.
  • The role of T3 addition to T4 therapy for hypothyroidism is re-evaluated.

Purpose:

  • To synthesize current evidence on the risks and benefits of specific hormone therapies.
  • To inform clinical practice regarding HRT, OCs, and hypothyroidism treatment.
  • To highlight potential dangers of adulterated Chinese herbal products.

Summary:

  • Convincing evidence indicates HRT risks surpass benefits for post-menopausal women.
  • Low-dose OCs significantly increase the risk of cardiac and arterial thrombotic events.

Related Experiment Videos

  • Adding T3 to T4 therapy for hypothyroidism offers no additional benefits.
  • Full replacement dose of T4 can be safely initiated in asymptomatic coronary heart disease patients.
  • Chinese herbal products may contain thyroid hormones or glucocorticoids, posing serious health risks.

    • Impact:

    • Clinical guidelines for HRT and OC use may require revision.
    • Treatment protocols for hypothyroidism may be simplified, focusing on T4 monotherapy.
    • Increased awareness of potential endocrine disruption from herbal supplements is crucial.
    • Patient safety can be enhanced through informed decision-making regarding hormone therapies and supplements.